17.01.2014 Views

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Fig. 1.39 Apocrine <strong>carcinoma</strong>. Note abundant<br />

eosinophilic cytoplasm and vesicular nuclei.<br />

Fig. 1.40 Apocrine <strong>carcinoma</strong>, surperficially resembling<br />

a granular cell tumour.<br />

Fig. 1.41 Apocrine <strong>carcinoma</strong>. Immunostaining shows<br />

intense positivity for GCDFP-15.<br />

to as myoblastomatoid {806}. Type B<br />

cell shows abundant cytoplasm in which<br />

fine empty vacuoles are seen. These latter<br />

result in foamy appearance so that<br />

the cells may resemble histiocytes and<br />

sebaceous cells. Nuclei are similar to<br />

those in type A cells. These same cells<br />

have been designated as sebocrine<br />

{2876}. (See also Sebaceous carc i n o-<br />

ma, page 46). C a rcinomas composed<br />

p u rely of foamy apocrine cells may<br />

s u r p e rfically resemble a histiocytic proliferation<br />

or even an inflammatory re a c-<br />

tion {806}. In difficult cases, both granular<br />

cell tumours and histiocytic pro l i f e r a-<br />

tions can be easily distinguished by<br />

staining the tumours with keratin antibodies<br />

that are positive only in apocrine<br />

c a rc i n o m a s .<br />

Immunoprofile<br />

Apocrine <strong>carcinoma</strong>s are typically<br />

GCDFP-15 positive and BCL2 pro t e i n<br />

negative. Expression of GCDFP-15 is a<br />

f e a t u re common to many variants of<br />

b reast <strong>carcinoma</strong>, however, and has<br />

been used to support <strong>breast</strong> origin in<br />

metastatic <strong>carcinoma</strong>s of unknown prim<br />

a ry site. Estrogen and pro g e s t e ro n e<br />

receptors are usually negative in apocrine<br />

<strong>carcinoma</strong> by immonuhistochemical<br />

assessment. Interestingly, many ER-,<br />

PR- apocrine <strong>carcinoma</strong>s do have the<br />

ERmRNA, but fail to produce the pro t e i n<br />

{336}. The expression of other biological<br />

markers is in general similar to that<br />

of other <strong>carcinoma</strong>s {177,1605,2425}.<br />

A n d rogen receptors have been re p o rted<br />

as positive in 97% of ADCIS in one<br />

series {1605} and 81% in another<br />

{2624}. Sixty-two percent of invasive<br />

duct <strong>carcinoma</strong>s were positive in the<br />

latter series {2624} and in 22% of cases<br />

in another study {1874}. The significance<br />

of AR in apocrine <strong>carcinoma</strong>s is<br />

u n c e rt a i n .<br />

G e n e t i c s<br />

Molecular studies in benign, hyperplastic<br />

and neoplastic apocrine lesions parallel<br />

those seen in non apocrine<br />

tumours {1357,1673}.<br />

Prognosis and predictive factors<br />

Survival analysis of 72 cases of invasive<br />

apocrine duct <strong>carcinoma</strong> compared with<br />

non apocrine duct <strong>carcinoma</strong> re v e a l e d<br />

no statistical diff e rence {17,809}.<br />

Metaplastic <strong>carcinoma</strong>s<br />

D e f i n i t i o n<br />

Metaplastic <strong>carcinoma</strong> is a general<br />

t e rm referring to a hetero g e n e o u s<br />

g roup of neoplasms generally characterized<br />

by an intimate admixture of aden<br />

o c a rcinoma with dominant areas of<br />

spindle cell, squamous, and/or mesenchymal<br />

diff e rentiation; the metaplastic<br />

spindle cell and squamous cell <strong>carcinoma</strong>s<br />

may present in a pure form<br />

without any admixture with a re c o g n i z a-<br />

ble adeno<strong>carcinoma</strong>. Metaplastic carc i-<br />

nomas can be classified into bro a d<br />

subtypes according to the phenotypic<br />

appearance of the tumour.<br />

ICD-O code 8 5 7 5 / 3<br />

S y n o n y m s<br />

Matrix producing <strong>carcinoma</strong>, carc i n o-<br />

s a rcoma, spindle cell carc i n o m a .<br />

E p i d e m i o l o g y<br />

Metaplastic <strong>carcinoma</strong>s account for<br />

less than 1% of all invasive mammary<br />

c a rcinomas {1273}. The average age at<br />

p resentation is 55.<br />

Clinical features<br />

Clinical presentation is not diff e rent fro m<br />

that of infiltrating duct NOS carc i n o m a .<br />

Most patients present with a well circ u m-<br />

scribed palpable mass, with a median<br />

size of 3-4 cm, in some re p o rts more<br />

than half of these tumours measure over<br />

5 cm, with some massive lesions (>20<br />

cm) which may displace the nipple and<br />

ulcerate through the skin.<br />

On mammography, most metaplastic<br />

c a rcinomas appear as well delineated<br />

mass densities. Microcalcifications are<br />

not a common feature, but may be pre s-<br />

ent in the adeno<strong>carcinoma</strong>tous are a s ;<br />

ossification, when present, is, of course,<br />

a p p a rent on mammography.<br />

Macroscopy<br />

The tumours are firm, well delineated<br />

and often solid on cut surface. Squamous<br />

or chondroid diff e rentiation is<br />

reflected as pearly white to firm glistening<br />

areas on the cut surface. One large<br />

and/or multiple small cysts may be<br />

a p p a rent on the cut surface of larger<br />

squamous tumours.<br />

Table 1.08<br />

Classification of metaplastic <strong>carcinoma</strong>s.<br />

Purely epithelial<br />

Squamous<br />

Large cell keratinizing<br />

Spindle cell<br />

Acantholytic<br />

Adeno<strong>carcinoma</strong> with spindle cell differentiation<br />

Adenosquamous, including mucoepidermoid<br />

Mixed epithelial and Mesenchymal<br />

(specify components)<br />

Carcinoma with chondroid metaplasia<br />

Carcinoma with osseous metaplasia<br />

Carcinosarcoma (specify components)<br />

<strong>Invasive</strong> <strong>breast</strong> cancer<br />

37

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!